(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of VDR mRNA CTD PMID:18534255 (R)-noradrenaline increases abundance ISO RGD:619561 6480464 VDR protein results in increased abundance of Norepinephrine CTD PMID:27450565 1,2-dimethylhydrazine decreases expression ISO RGD:11484 6480464 1, 2-Dimethylhydrazine results in decreased expression of VDR mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:11484 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VDR mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:619561 6480464 Dinitrochlorobenzene results in increased expression of VDR mRNA CTD PMID:17374397 17alpha-ethynylestradiol multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein], VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of VDR mRNA, Ethinyl Estradiol results in increased expression of VDR protein CTD PMID:20186393 17beta-estradiol multiple interactions ISO RGD:619561 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of VDR mRNA] more ... CTD PMID:15930183 more ... 17beta-estradiol decreases expression ISO RGD:619561 6480464 Estradiol results in decreased expression of VDR mRNA CTD PMID:31646340 17beta-estradiol increases expression ISO RGD:619561 6480464 Estradiol results in increased expression of VDR mRNA, Estradiol results in increased expression of VDR protein CTD PMID:15930183 more ... 17beta-estradiol multiple interactions EXP 6480464 Tamoxifen inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:1315250 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of VDR protein CTD PMID:1315250 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11484 6480464 Tetrachlorodibenzodioxin results in increased expression of VDR mRNA CTD PMID:15667827 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VDR mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:619561 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of VDR mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11484 6480464 Tetrachlorodibenzodioxin results in decreased expression of VDR mRNA CTD PMID:24035824 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:619561 6480464 Tetrachlorodibenzodioxin results in increased expression of VDR mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11484 6480464 Tetrachlorodibenzodioxin affects the expression of VDR mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11484 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to VDR promoter] CTD PMID:19654925 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:619561 6480464 2 more ... CTD PMID:26705709 24,25-Dihydroxyvitamin D increases activity ISO RGD:11484 6480464 24, 25-Dihydroxyvitamin D 3 results in increased activity of VDR protein CTD PMID:17997857 24,25-Dihydroxyvitamin D increases activity ISO RGD:619561 6480464 24, 25-Dihydroxyvitamin D 3 results in increased activity of VDR protein CTD PMID:17997857 3,7-dihydropurine-6-thione affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Mercaptopurine CTD PMID:15713801 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:11484 6480464 bisindolylmaleimide I inhibits the reaction [1, 25-dihydroxyvitamin D results in increased activity of VDR protein] CTD PMID:18829283 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [Calcitriol results in increased expression of VDR mRNA] more ... CTD PMID:20006981 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:619561 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of VDR protein CTD PMID:33836827 3-methoxytyramine increases abundance ISO RGD:619561 6480464 VDR protein results in increased abundance of 3-methoxytyramine CTD PMID:27450565 3-methoxytyramine multiple interactions ISO RGD:619561 6480464 Calcitriol promotes the reaction [VDR protein results in increased abundance of 3-methoxytyramine] CTD PMID:27450565 3-oxo-5beta-cholanic acid increases activity ISO RGD:619561 6480464 3-oxocholan-24-oic acid results in increased activity of VDR protein CTD PMID:15708356 3-phenoxybenzoic acid affects binding ISO RGD:619561 6480464 3-phenoxybenzoic acid binds to VDR protein CTD PMID:32278787 4-hydroxyphenyl retinamide multiple interactions ISO RGD:619561 6480464 Cholecalciferol promotes the reaction [Fenretinide results in increased expression of VDR] CTD PMID:17024972 4-hydroxyphenyl retinamide increases expression ISO RGD:11484 6480464 Fenretinide results in increased expression of VDR mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:619561 6480464 Fenretinide results in increased expression of VDR CTD PMID:17024972 5-aza-2'-deoxycytidine multiple interactions ISO RGD:619561 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of VDR mRNA, [Decitabine co-treated with trichostatin A] results in increased expression of VDR protein CTD PMID:17891453 8-Br-cAMP increases expression ISO RGD:619561 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VDR mRNA CTD PMID:22079614 9-cis-retinoic acid multiple interactions ISO RGD:619561 6480464 [Alitretinoin co-treated with Calcitriol] results in increased stability of [RXRA protein binds to VDR protein], Alitretinoin promotes the reaction [VDR protein binds to BGLAP gene] CTD PMID:12898515 , PMID:16204233 9-cis-retinoic acid affects activity ISO RGD:619561 6480464 Alitretinoin affects the activity of VDR protein CTD PMID:16936639 9-cis-retinoic acid increases degradation ISO RGD:619561 6480464 Alitretinoin results in increased degradation of VDR protein CTD PMID:12898515 acetylsalicylic acid affects response to substance ISO RGD:619561 6480464 VDR polymorphism affects the susceptibility to Aspirin CTD PMID:15066917 afimoxifene decreases expression ISO RGD:619561 6480464 afimoxifene results in decreased expression of VDR protein CTD PMID:8593782 aflatoxin B1 increases expression ISO RGD:619561 6480464 Aflatoxin B1 results in increased expression of VDR mRNA CTD PMID:22100608 , PMID:32234424 aflatoxin B1 decreases expression ISO RGD:619561 6480464 Aflatoxin B1 results in decreased expression of VDR mRNA, Aflatoxin B1 results in decreased expression of VDR protein CTD PMID:25483621 aflatoxin B1 affects response to substance ISO RGD:619561 6480464 VDR polymorphism affects the susceptibility to Aflatoxin B1 CTD PMID:25483621 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of VDR mRNA CTD PMID:23630614 , PMID:25378103 aldehydo-D-glucose multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA more ... CTD PMID:21788014 alendronic acid affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Alendronate CTD PMID:12608943 , PMID:15739035 alendronic acid multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to [Alendronate co-treated with Estrogens more ... CTD PMID:15739035 alfacalcidol increases activity ISO RGD:619561 6480464 alfacalcidol results in increased activity of VDR protein CTD PMID:17997857 alfacalcidol multiple interactions ISO RGD:619561 6480464 alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to MED1 protein modified form], alfacalcidol promotes the reaction [[VDR protein binds to RXRA protein] which binds to NCOA1 protein modified form] CTD PMID:20947021 alfacalcidol multiple interactions ISO RGD:11484 6480464 [alfacalcidol results in increased activity of VDR protein] which results in increased metabolism of Bile Acids and Salts CTD PMID:19581390 alfacalcidol increases activity ISO RGD:11484 6480464 alfacalcidol results in increased activity of VDR protein CTD PMID:17997857 , PMID:19581390 alfacalcidol affects binding ISO RGD:619561 6480464 alfacalcidol binds to [VDR protein binds to RXRA protein], alfacalcidol binds to VDR protein modified form CTD PMID:20947021 all-trans-retinoic acid multiple interactions ISO RGD:619561 6480464 [Cholecalciferol co-treated with Tretinoin] promotes the reaction [[VDR protein binds to RXRA protein] which binds to SLCO1A2 promoter] more ... CTD PMID:11504768 more ... all-trans-retinoic acid increases expression ISO RGD:619561 6480464 Tretinoin results in increased expression of VDR mRNA, Tretinoin results in increased expression of VDR protein CTD PMID:33167477 , PMID:7662588 alpha-linolenic acid increases expression ISO RGD:619561 6480464 alpha-Linolenic Acid results in increased expression of VDR mRNA CTD PMID:19667161 alpha-linolenic acid multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with alpha-Linolenic Acid] results in increased expression of VDR mRNA CTD PMID:19667161 alpha-naphthoflavone multiple interactions ISO RGD:619561 6480464 alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]] CTD PMID:19244278 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of VDR mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:619561 6480464 pyrazolanthrone inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:15930183 antirheumatic drug decreases expression ISO RGD:619561 6480464 Antirheumatic Agents results in decreased expression of VDR mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:619561 6480464 aristolochic acid I results in increased expression of VDR mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:619561 6480464 arsenite results in decreased expression of VDR mRNA, arsenite results in decreased expression of VDR protein CTD PMID:15037631 , PMID:31646340 bafilomycin A1 multiple interactions ISO RGD:619561 6480464 [bafilomycin A1 co-treated with Vitamin D] results in increased expression of VDR protein, [Silicon Dioxide co-treated with Vitamin D co-treated with bafilomycin A1] results in increased expression of VDR protein CTD PMID:30698894 benzene increases expression ISO RGD:11484 6480464 Benzene results in increased expression of VDR mRNA CTD PMID:12928149 benzo[a]pyrene multiple interactions ISO RGD:11484 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to VDR promoter] CTD PMID:19654925 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of VDR mRNA CTD PMID:34283317 benzo[a]pyrene increases expression ISO RGD:619561 6480464 Benzo(a)pyrene results in increased expression of VDR mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:619561 6480464 Benzo(a)pyrene results in decreased methylation of VDR 5' UTR, Benzo(a)pyrene results in decreased methylation of VDR promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:11484 6480464 Benzo(a)pyrene results in decreased expression of VDR mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with Benzo(a)pyrene] results in increased expression of VDR protein more ... CTD PMID:19244278 , PMID:22837390 bezafibrate multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with Bezafibrate] results in increased expression of VDR mRNA CTD PMID:19667161 biphenyl-2-ol affects binding ISO RGD:619561 6480464 2-phenylphenol binds to VDR protein CTD PMID:32278787 bisdemethoxycurcumin multiple interactions ISO RGD:619561 6480464 [bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of VDR mRNA CTD PMID:22029407 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of VDR mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:619561 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of VDR protein CTD PMID:33836827 bisphenol A multiple interactions ISO RGD:11484 6480464 [bisphenol A co-treated with Cholecalciferol] results in increased expression of VDR mRNA, [bisphenol A co-treated with Cholecalciferol] results in increased expression of VDR protein CTD PMID:32702508 bisphenol A decreases expression ISO RGD:11484 6480464 bisphenol A results in decreased expression of VDR mRNA CTD PMID:30951980 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VDR mRNA CTD PMID:30816183 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of VDR gene CTD PMID:28505145 butanal increases expression ISO RGD:619561 6480464 butyraldehyde results in increased expression of VDR mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:619561 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VDR mRNA more ... CTD PMID:31646340 , PMID:35301059 cadmium atom decreases expression ISO RGD:619561 6480464 Cadmium results in decreased expression of VDR mRNA CTD PMID:31646340 cadmium dichloride multiple interactions ISO RGD:619561 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VDR mRNA, Cadmium Chloride promotes the reaction [VDR protein binds to NCOA2 protein] CTD PMID:21229763 , PMID:35301059 cadmium dichloride decreases expression ISO RGD:619561 6480464 Cadmium Chloride results in decreased expression of VDR mRNA CTD PMID:25596134 calcidiol increases activity ISO RGD:11484 6480464 Calcifediol results in increased activity of VDR protein CTD PMID:17997857 , PMID:21291553 calcidiol increases activity ISO RGD:619561 6480464 Calcifediol results in increased activity of VDR protein, Calcifediol results in increased activity of VDR protein mutant form CTD PMID:17997857 , PMID:21291553 calcidiol multiple interactions ISO RGD:619561 6480464 Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein] more ... CTD PMID:20079722 , PMID:24792400 calciol multiple interactions ISO RGD:619561 6480464 [Cholecalciferol binds to VDR protein] which results in increased expression of SLCO1A2 mRNA more ... CTD PMID:17024972 more ... calciol multiple interactions EXP 6480464 Cholecalciferol inhibits the reaction [Dietary Fats results in decreased expression of VDR mRNA], Cholecalciferol inhibits the reaction [Gentamicins results in decreased expression of VDR protein] CTD PMID:29653100 , PMID:30458643 calciol multiple interactions ISO RGD:11484 6480464 [bisphenol A co-treated with Cholecalciferol] results in increased expression of VDR mRNA more ... CTD PMID:17008384 more ... calciol increases expression ISO RGD:619561 6480464 Cholecalciferol results in increased expression of VDR CTD PMID:17024972 calcipotriol affects response to substance ISO RGD:619561 6480464 VDR promoter SNP affects the susceptibility to calcipotriene CTD PMID:15864137 calcipotriol increases expression ISO RGD:619561 6480464 calcipotriene results in increased expression of VDR protein CTD PMID:30419252 calcipotriol multiple interactions ISO RGD:619561 6480464 calcipotriene affects the reaction [Calcitriol binds to VDR protein] more ... CTD PMID:30419252 , PMID:7530193 calcitriol multiple interactions ISO RGD:619561 6480464 1 more ... CTD PMID:10799658 more ... calcitriol increases expression ISO RGD:619561 6480464 Calcitriol results in increased expression of VDR mRNA, Calcitriol results in increased expression of VDR protein CTD PMID:11158396 more ... calcitriol increases phosphorylation ISO RGD:619561 6480464 Calcitriol results in increased phosphorylation of VDR protein CTD PMID:20371703 calcitriol affects binding EXP 6480464 Calcitriol analog binds to VDR protein, Calcitriol binds to VDR protein CTD PMID:17110116 more ... calcitriol increases activity ISO RGD:11484 6480464 Calcitriol results in increased activity of VDR protein CTD PMID:17997857 , PMID:21291553 calcitriol increases response to substance ISO RGD:11484 6480464 VDR results in increased susceptibility to Calcitriol CTD PMID:17035339 calcitriol increases expression ISO RGD:11484 6480464 Calcitriol results in increased expression of VDR mRNA, Calcitriol results in increased expression of VDR protein CTD PMID:16368784 more ... calcitriol decreases degradation ISO RGD:11484 6480464 Calcitriol results in decreased degradation of VDR protein CTD PMID:16467308 calcitriol multiple interactions ISO RGD:11484 6480464 Calcitriol binds to and results in increased activity of VDR protein mutant form more ... CTD PMID:15647825 more ... calcitriol affects localization ISO RGD:11484 6480464 Calcitriol affects the localization of VDR protein CTD PMID:15647825 calcitriol affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Calcitriol CTD PMID:15861036 calcitriol increases localization ISO RGD:619561 6480464 Calcitriol results in increased localization of VDR protein CTD PMID:16204233 calcitriol increases activity ISO RGD:619561 6480464 Calcitriol results in increased activity of VDR protein more ... CTD PMID:15992766 more ... calcitriol decreases expression ISO RGD:619561 6480464 Calcitriol results in decreased expression of VDR mRNA CTD PMID:16002434 calcitriol affects binding ISO RGD:619561 6480464 [Calcitriol binds to VDR protein] which binds to HOXA10 promoter more ... CTD PMID:10875257 more ... calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of VDR more ... CTD PMID:15746989 more ... calcitriol multiple interactions EXP 6480464 1 more ... CTD PMID:20006981 more ... calcium atom affects metabolic processing ISO RGD:619561 6480464 VDR gene polymorphism affects the metabolism of Calcium CTD PMID:15883634 , PMID:16048257 calcium atom affects abundance ISO RGD:11484 6480464 VDR protein affects the abundance of Calcium CTD PMID:11500311 calcium atom affects expression EXP 6480464 Calcium affects the expression of VDR mRNA CTD PMID:15913539 calcium atom affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Calcium CTD PMID:15861036 calcium(0) affects metabolic processing ISO RGD:619561 6480464 VDR gene polymorphism affects the metabolism of Calcium CTD PMID:15883634 , PMID:16048257 calcium(0) affects abundance ISO RGD:11484 6480464 VDR protein affects the abundance of Calcium CTD PMID:11500311 calcium(0) affects expression EXP 6480464 Calcium affects the expression of VDR mRNA CTD PMID:15913539 calcium(0) affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Calcium CTD PMID:15861036 captopril multiple interactions ISO RGD:11484 6480464 Captopril promotes the reaction [LEPR protein affects the expression of VDR protein] CTD PMID:28130181 carbon nanotube decreases expression ISO RGD:11484 6480464 Nanotubes, Carbon results in decreased expression of VDR mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:11484 6480464 Nanotubes, Carbon results in increased expression of VDR mRNA CTD PMID:31978390 carnosic acid multiple interactions ISO RGD:619561 6480464 Calcitriol promotes the reaction [salvin results in increased expression of VDR protein] more ... CTD PMID:11504768 carnosic acid increases expression ISO RGD:619561 6480464 salvin results in increased expression of VDR protein CTD PMID:11504768 cefalotin multiple interactions ISO RGD:11484 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA CTD PMID:24657338 CGP 52608 multiple interactions ISO RGD:619561 6480464 CGP 52608 promotes the reaction [RORA protein binds to VDR gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [Chenodeoxycholic Acid results in increased expression of VDR mRNA], Chenodeoxycholic Acid promotes the reaction [Calcitriol results in increased expression of VDR mRNA] CTD PMID:20006981 chenodeoxycholic acid increases expression EXP 6480464 Chenodeoxycholic Acid results in increased expression of VDR mRNA CTD PMID:20006981 chenodeoxycholic acid increases expression ISO RGD:619561 6480464 Chenodeoxycholic Acid results in increased expression of VDR mRNA CTD PMID:20006981 CHIR 99021 decreases expression EXP 6480464 Chir 99021 results in decreased expression of VDR mRNA, Chir 99021 results in decreased expression of VDR protein CTD PMID:34283317 chloroacetaldehyde decreases expression ISO RGD:619561 6480464 chloroacetaldehyde results in decreased expression of VDR mRNA CTD PMID:25596134 cholanic acid multiple interactions ISO RGD:619561 6480464 cholanic acid binds to and results in increased activity of VDR protein, cholanic acid binds to and results in increased activity of VDR protein mutant form CTD PMID:21291553 cholanic acid multiple interactions ISO RGD:11484 6480464 cholanic acid binds to and results in increased activity of VDR protein, cholanic acid binds to and results in increased activity of VDR protein mutant form CTD PMID:21291553 cholesterol affects binding ISO RGD:619561 6480464 Cholesterol metabolite binds to VDR protein CTD PMID:16051528 cholesterol affects abundance ISO RGD:619561 6480464 VDR gene SNP affects the abundance of Cholesterol CTD PMID:25498546 cholic acid increases localization ISO RGD:619561 6480464 Cholic Acid results in increased localization of VDR protein CTD PMID:20371703 chromium(6+) affects expression ISO RGD:11484 6480464 chromium hexavalent ion affects the expression of VDR mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:11484 6480464 Ciguatoxins affects the expression of VDR mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:619561 6480464 Cisplatin results in increased expression of VDR mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:11484 6480464 Cisplatin results in decreased expression of VDR mRNA CTD PMID:35403300 copper(II) sulfate decreases expression ISO RGD:619561 6480464 Copper Sulfate results in decreased expression of VDR mRNA CTD PMID:19549813 curcumin multiple interactions ISO RGD:619561 6480464 [Curcumin binds to and results in increased activity of VDR protein] which results in increased expression of CDKN1A mRNA more ... CTD PMID:20153625 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of VDR mRNA CTD PMID:27281708 cyclosporin A decreases expression ISO RGD:619561 6480464 Cyclosporine results in decreased expression of VDR mRNA CTD PMID:25596134 cytarabine affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Cytarabine CTD PMID:15713801 D-glucose multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA more ... CTD PMID:21788014 daunorubicin decreases activity ISO RGD:619561 6480464 Daunorubicin results in decreased activity of VDR protein CTD PMID:25257666 daunorubicin affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Daunorubicin CTD PMID:15713801 desferrioxamine B increases expression ISO RGD:619561 6480464 Deferoxamine results in increased expression of VDR mRNA CTD PMID:20368581 dexamethasone multiple interactions ISO RGD:11484 6480464 Dexamethasone promotes the reaction [1, 25-dihydroxyvitamin D results in increased expression of VDR protein] CTD PMID:11751517 dexamethasone multiple interactions ISO RGD:619561 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of VDR protein CTD PMID:33836827 dexamethasone increases expression ISO RGD:11484 6480464 Dexamethasone results in increased expression of VDR mRNA CTD PMID:10694374 , PMID:22733784 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of VDR mRNA CTD PMID:20006981 dexamethasone increases expression ISO RGD:619561 6480464 Dexamethasone results in increased expression of VDR mRNA CTD PMID:20006981 dextran sulfate multiple interactions ISO RGD:11484 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VDR mRNA CTD PMID:29950665 dibutyl phthalate decreases expression ISO RGD:11484 6480464 Dibutyl Phthalate results in decreased expression of VDR mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:619561 6480464 dicrotophos results in increased expression of VDR mRNA CTD PMID:28302478 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of VDR mRNA CTD PMID:16122865 dioxygen decreases expression ISO RGD:619561 6480464 Oxygen deficiency results in decreased expression of VDR mRNA CTD PMID:25596134 disodium selenite decreases expression ISO RGD:619561 6480464 Sodium Selenite results in decreased expression of VDR mRNA CTD PMID:16928829 dopamine increases abundance ISO RGD:619561 6480464 VDR protein results in increased abundance of Dopamine CTD PMID:27450565 dorsomorphin multiple interactions ISO RGD:619561 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VDR mRNA CTD PMID:27188386 doxorubicin decreases activity ISO RGD:619561 6480464 Doxorubicin results in decreased activity of VDR protein CTD PMID:25257666 doxorubicin decreases expression ISO RGD:619561 6480464 Doxorubicin results in decreased expression of VDR mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:619561 6480464 Doxorubicin results in increased expression of VDR mRNA CTD PMID:17716971 endosulfan multiple interactions ISO RGD:619561 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of VDR mRNA CTD PMID:26159488 entinostat increases expression ISO RGD:619561 6480464 entinostat results in increased expression of VDR mRNA CTD PMID:27188386 estriol increases expression ISO RGD:619561 6480464 Estriol results in increased expression of VDR mRNA CTD PMID:14992164 , PMID:15775415 etoposide multiple interactions ISO RGD:619561 6480464 [[Etoposide results in increased expression of TP73 protein] which results in increased expression of VDR protein] which results in increased susceptibility to Calcitriol, TP73 protein affects the reaction [Etoposide results in increased expression of VDR mRNA] CTD PMID:17716971 etoposide affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Etoposide, VDR intron polymorphism affects the susceptibility to Etoposide CTD PMID:12969965 , PMID:15713801 etoposide increases expression ISO RGD:619561 6480464 Etoposide results in increased expression of VDR mRNA CTD PMID:17716971 eugenol increases expression ISO RGD:619561 6480464 Eugenol results in increased expression of VDR mRNA CTD PMID:17374397 Falecalcitriol multiple interactions ISO RGD:619561 6480464 26 more ... CTD PMID:16059639 Falecalcitriol increases activity ISO RGD:619561 6480464 26 more ... CTD PMID:16059639 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of VDR mRNA CTD PMID:30307764 flucythrinate affects binding ISO RGD:619561 6480464 flucythrinate binds to VDR protein CTD PMID:32278787 folic acid increases expression ISO RGD:11484 6480464 Folic Acid results in increased expression of VDR mRNA CTD PMID:30405444 folic acid multiple interactions ISO RGD:11484 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VDR mRNA CTD PMID:22206623 fulvestrant multiple interactions ISO RGD:619561 6480464 Cadmium inhibits the reaction [Fulvestrant results in decreased expression of VDR mRNA] more ... CTD PMID:17088408 , PMID:31646340 fulvestrant decreases expression ISO RGD:619561 6480464 Fulvestrant results in decreased expression of VDR mRNA, Fulvestrant results in decreased expression of VDR protein CTD PMID:15930183 , PMID:31646340 gamma-tocopherol increases expression ISO RGD:619561 6480464 Tocopherols results in increased expression of VDR mRNA CTD PMID:12032296 genistein multiple interactions ISO RGD:619561 6480464 fulvestrant inhibits the reaction [Genistein results in increased expression of VDR protein] more ... CTD PMID:12710998 more ... genistein increases expression ISO RGD:619561 6480464 Genistein results in increased expression of VDR mRNA, Genistein results in increased expression of VDR protein CTD PMID:12710998 , PMID:17088408 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of VDR protein CTD PMID:30458643 gentamycin multiple interactions EXP 6480464 Cholecalciferol inhibits the reaction [Gentamicins results in decreased expression of VDR protein] CTD PMID:30458643 glucose multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA more ... CTD PMID:21788014 glycitein multiple interactions ISO RGD:619561 6480464 fulvestrant inhibits the reaction [glycitein results in increased expression of VDR protein] more ... CTD PMID:17088408 glycitein increases expression ISO RGD:619561 6480464 glycitein results in increased expression of VDR mRNA, glycitein results in increased expression of VDR protein CTD PMID:17088408 Goe 6976 multiple interactions ISO RGD:619561 6480464 Go 6976 inhibits the reaction [isopentenyl pyrophosphate results in increased expression of VDR protein] CTD PMID:15879110 Goe 6976 multiple interactions ISO RGD:11484 6480464 Go 6976 inhibits the reaction [1, 25-dihydroxyvitamin D results in increased activity of VDR protein] CTD PMID:18829283 guggulsterone multiple interactions ISO RGD:11484 6480464 pregna-4 more ... CTD PMID:17959142 GW 501516 multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with GW 501516] results in increased expression of VDR mRNA CTD PMID:19667161 GW 501516 increases expression ISO RGD:619561 6480464 GW 501516 results in increased expression of VDR mRNA CTD PMID:19667161 hexachlorobenzene multiple interactions ISO RGD:11484 6480464 [Hexachlorobenzene co-treated with Diethylnitrosamine] results in decreased expression of VDR protein, Cholecalciferol inhibits the reaction [[Hexachlorobenzene co-treated with Diethylnitrosamine] results in increased expression of VDR protein] CTD PMID:28634113 homovanillic acid multiple interactions ISO RGD:619561 6480464 Calcitriol promotes the reaction [VDR protein results in increased abundance of Homovanillic Acid] CTD PMID:27450565 homovanillic acid increases abundance ISO RGD:619561 6480464 VDR protein results in increased abundance of Homovanillic Acid CTD PMID:27450565 idarubicin decreases activity ISO RGD:619561 6480464 Idarubicin results in decreased activity of VDR protein CTD PMID:25257666 iron atom increases expression ISO RGD:619561 6480464 Iron deficiency results in increased expression of VDR mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:619561 6480464 Iron deficiency results in increased expression of VDR mRNA CTD PMID:20368581 isopentenyl diphosphate multiple interactions ISO RGD:619561 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [isopentenyl pyrophosphate results in increased expression of VDR protein] more ... CTD PMID:15879110 isopentenyl diphosphate increases expression ISO RGD:619561 6480464 isopentenyl pyrophosphate results in increased expression of VDR protein CTD PMID:15879110 kaempferol increases activity ISO RGD:619561 6480464 kaempferol results in increased activity of VDR protein CTD PMID:26366751 ketoconazole multiple interactions ISO RGD:619561 6480464 Ketoconazole inhibits the reaction [Calcifediol promotes the reaction [[[CD3G protein binds to CD3D protein binds to CD3E protein binds to CD247 protein] which co-treated with CD28 protein] results in increased expression of VDR protein]], Ketoconazole inhibits the reaction [Vitamin D analog results in increased activity of VDR protein] CTD PMID:16280049 , PMID:24792400 lacidipine increases activity ISO RGD:619561 6480464 lacidipine results in increased activity of VDR protein CTD PMID:25257666 lactacystin decreases degradation ISO RGD:619561 6480464 lactacystin results in decreased degradation of VDR protein CTD PMID:24792400 lamivudine multiple interactions ISO RGD:11484 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of VDR mRNA CTD PMID:11741158 lead diacetate multiple interactions ISO RGD:619561 6480464 lead acetate promotes the reaction [VDR protein binds to NCOA2 protein] CTD PMID:21229763 lead(0) affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Lead more ... CTD PMID:11049814 more ... lead(0) increases response to substance ISO RGD:619561 6480464 VDR gene polymorphism results in increased susceptibility to Lead, VDR gene SNP results in increased susceptibility to Lead CTD PMID:22101007 , PMID:32340109 lead(0) affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of Lead CTD PMID:19515364 more ... lead(0) multiple interactions ISO RGD:619561 6480464 [VDR gene polymorphism co-treated with ALAD gene polymorphism] affects the abundance of Lead CTD PMID:19515364 lead(2+) affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of Lead CTD PMID:19515364 more ... lead(2+) multiple interactions ISO RGD:619561 6480464 [VDR gene polymorphism co-treated with ALAD gene polymorphism] affects the abundance of Lead CTD PMID:19515364 lead(2+) affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Lead more ... CTD PMID:11049814 more ... lead(2+) increases response to substance ISO RGD:619561 6480464 VDR gene polymorphism results in increased susceptibility to Lead, VDR gene SNP results in increased susceptibility to Lead CTD PMID:22101007 , PMID:32340109 levonorgestrel multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein], VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Glucose] results in decreased expression of VDR mRNA more ... CTD PMID:21788014 lipopolysaccharide multiple interactions ISO RGD:619561 6480464 Lipopolysaccharides inhibits the reaction [Calcitriol results in increased expression of VDR protein], Lipopolysaccharides results in decreased expression of and results in decreased activity of VDR protein CTD PMID:15876428 lithocholic acid multiple interactions ISO RGD:11484 6480464 Lithocholic Acid binds to and results in increased activity of VDR protein more ... CTD PMID:15824121 more ... lithocholic acid affects binding ISO RGD:619561 6480464 Lithocholic Acid analog binds to VDR protein more ... CTD PMID:14525957 more ... lithocholic acid increases phosphorylation ISO RGD:619561 6480464 Lithocholic Acid results in increased phosphorylation of VDR protein CTD PMID:20371703 lithocholic acid affects binding EXP 6480464 Lithocholic Acid binds to VDR protein CTD PMID:19562681 , PMID:23723390 lithocholic acid increases expression ISO RGD:619561 6480464 Lithocholic Acid results in increased expression of VDR mRNA, Lithocholic Acid results in increased expression of VDR protein CTD PMID:20006981 , PMID:31472180 lithocholic acid decreases expression EXP 6480464 Lithocholic Acid results in decreased expression of VDR mRNA CTD PMID:20006981 lithocholic acid multiple interactions EXP 6480464 [Lithocholic Acid binds to and results in increased activity of VDR protein] which results in increased expression of CYP24A1 mRNA more ... CTD PMID:19562681 , PMID:21311750 lithocholic acid increases activity ISO RGD:619561 6480464 Lithocholic Acid metabolite results in increased activity of VDR protein, Lithocholic Acid results in increased activity of VDR protein CTD PMID:21543282 more ... lithocholic acid multiple interactions ISO RGD:619561 6480464 [Lithocholic Acid analog binds to and results in increased activity of VDR protein] which results in increased expression of CYP24A1 mRNA more ... CTD PMID:15489543 more ... LY294002 multiple interactions ISO RGD:619561 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein inhibits the reaction [1, 25-dihydroxyvitamin D results in increased activity of VDR protein]] CTD PMID:18829283 manidipine increases activity ISO RGD:619561 6480464 manidipine results in increased activity of VDR protein CTD PMID:25257666 Maxacalcitol multiple interactions ISO RGD:619561 6480464 maxacalcitol affects the reaction [Calcitriol binds to VDR protein] CTD PMID:7530193 medroxyprogesterone acetate multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to [Alendronate co-treated with Estrogens more ... CTD PMID:15739035 mercaptopurine affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Mercaptopurine CTD PMID:15713801 mercury atom affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of Mercury CTD PMID:25728017 mercury(0) affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of Mercury CTD PMID:25728017 methotrexate affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Methotrexate CTD PMID:15713801 methotrexate increases expression ISO RGD:619561 6480464 Methotrexate results in increased expression of VDR mRNA CTD PMID:21678067 methoxsalen multiple interactions ISO RGD:619561 6480464 Methoxsalen affects the reaction [VDR protein affects the expression of CYP7A1 protein], VDR protein affects the reaction [Methoxsalen results in increased expression of NR0B2 protein] CTD PMID:30419252 methoxsalen increases expression ISO RGD:619561 6480464 Methoxsalen results in increased expression of VDR protein CTD PMID:30419252 methyl beta-cyclodextrin multiple interactions ISO RGD:619561 6480464 methyl-beta-cyclodextrin inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:15930183 methylseleninic acid affects expression ISO RGD:619561 6480464 methylselenic acid affects the expression of VDR mRNA CTD PMID:16928829 N-nitrosodiethylamine multiple interactions ISO RGD:11484 6480464 [Hexachlorobenzene co-treated with Diethylnitrosamine] results in decreased expression of VDR protein, Cholecalciferol inhibits the reaction [[Hexachlorobenzene co-treated with Diethylnitrosamine] results in increased expression of VDR protein] CTD PMID:28634113 neomycin multiple interactions ISO RGD:11484 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA CTD PMID:24657338 nickel atom multiple interactions ISO RGD:619561 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of VDR mRNA] CTD PMID:14575637 nickel atom affects expression ISO RGD:619561 6480464 Nickel affects the expression of VDR mRNA CTD PMID:14575637 nickel sulfate increases expression ISO RGD:619561 6480464 nickel sulfate results in increased expression of VDR mRNA CTD PMID:17374397 , PMID:22714537 O-methyleugenol increases expression ISO RGD:619561 6480464 methyleugenol results in increased expression of VDR mRNA CTD PMID:32234424 okadaic acid multiple interactions ISO RGD:619561 6480464 [1 more ... CTD PMID:16059639 paracetamol increases expression ISO RGD:619561 6480464 Acetaminophen results in increased expression of VDR mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of VDR mRNA CTD PMID:32680482 paricalcitol multiple interactions ISO RGD:619561 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of VDR protein more ... CTD PMID:16076355 , PMID:17715259 paricalcitol affects binding ISO RGD:619561 6480464 paricalcitol binds to VDR protein CTD PMID:15898824 pentanal increases expression ISO RGD:619561 6480464 pentanal results in increased expression of VDR mRNA CTD PMID:26079696 perfluorooctanoic acid multiple interactions ISO RGD:619561 6480464 perfluorooctanoic acid inhibits the reaction [Calcitriol binds to VDR protein] CTD PMID:33033332 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of VDR mRNA CTD PMID:19162173 phenothrin affects binding ISO RGD:619561 6480464 phenothrin binds to VDR protein CTD PMID:32278787 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:619561 6480464 Tetradecanoylphorbol Acetate promotes the reaction [salvin results in increased expression of VDR protein] CTD PMID:11504768 phorbol 13-acetate 12-myristate increases expression EXP 6480464 Tetradecanoylphorbol Acetate results in increased expression of VDR mRNA CTD PMID:20006981 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VDR mRNA] CTD PMID:20006981 phorbol 13-acetate 12-myristate increases expression ISO RGD:619561 6480464 Tetradecanoylphorbol Acetate results in increased expression of VDR mRNA, Tetradecanoylphorbol Acetate results in increased expression of VDR protein CTD PMID:20006981 , PMID:9348195 phosphorus atom affects expression ISO RGD:619561 6480464 Phosphorus affects the expression of VDR protein CTD PMID:17715259 phosphorus atom multiple interactions ISO RGD:619561 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of VDR protein, [Phosphorus co-treated with paricalcitol] results in increased localization of VDR protein CTD PMID:17715259 phosphorus(.) affects expression ISO RGD:619561 6480464 Phosphorus affects the expression of VDR protein CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:619561 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of VDR protein, [Phosphorus co-treated with paricalcitol] results in increased localization of VDR protein CTD PMID:17715259 pirinixic acid multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with pirinixic acid] results in increased expression of VDR mRNA CTD PMID:19667161 pirinixic acid increases expression ISO RGD:619561 6480464 pirinixic acid results in increased expression of VDR mRNA CTD PMID:19667161 potassium chromate decreases expression ISO RGD:619561 6480464 potassium chromate(VI) results in decreased expression of VDR mRNA CTD PMID:22714537 prednisone increases expression ISO RGD:619561 6480464 Prednisone results in increased expression of VDR protein CTD PMID:7662588 prednisone affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Prednisone CTD PMID:15713801 promegestone increases expression ISO RGD:619561 6480464 Promegestone results in increased expression of VDR protein CTD PMID:7662588 propanal increases expression ISO RGD:619561 6480464 propionaldehyde results in increased expression of VDR mRNA CTD PMID:26079696 purine-6-thiol affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Mercaptopurine CTD PMID:15713801 pyridaben increases activity ISO RGD:619561 6480464 pyridaben results in increased activity of VDR protein CTD PMID:20143881 quercetin multiple interactions ISO RGD:619561 6480464 VDR promotes the reaction [Quercetin results in increased expression of ABCB1 mRNA] more ... CTD PMID:26366751 quercetin increases response to substance ISO RGD:619561 6480464 VDR results in increased susceptibility to Quercetin CTD PMID:26366751 quercetin increases activity ISO RGD:619561 6480464 Quercetin results in increased activity of VDR protein CTD PMID:26366751 raloxifene affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Raloxifene Hydrochloride CTD PMID:15739035 , PMID:16604479 raloxifene multiple interactions ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to [Alendronate co-treated with Raloxifene Hydrochloride] CTD PMID:15739035 resveratrol multiple interactions ISO RGD:619561 6480464 [Calcitriol co-treated with resveratrol] results in increased expression of VDR mRNA more ... CTD PMID:12710998 more ... resveratrol increases expression ISO RGD:619561 6480464 resveratrol results in increased expression of VDR mRNA, resveratrol results in increased expression of VDR protein CTD PMID:12710998 , PMID:15280659 rotenone increases activity ISO RGD:619561 6480464 Rotenone results in increased activity of VDR protein CTD PMID:20143881 saracatinib multiple interactions ISO RGD:619561 6480464 saracatinib inhibits the reaction [Calcitriol results in increased phosphorylation of VDR protein], saracatinib inhibits the reaction [lithocholic acid acetate results in increased phosphorylation of VDR protein] CTD PMID:20371703 SB 431542 multiple interactions ISO RGD:619561 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VDR mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:619561 6480464 Silicon Dioxide analog results in increased expression of VDR mRNA CTD PMID:25895662 silicon dioxide multiple interactions ISO RGD:619561 6480464 [Silicon Dioxide co-treated with Vitamin D co-treated with bafilomycin A1] results in increased expression of VDR protein, [Silicon Dioxide co-treated with Vitamin D] results in increased expression of VDR protein CTD PMID:30698894 silicon dioxide multiple interactions ISO RGD:11484 6480464 [Silicon Dioxide co-treated with Vitamin D] results in increased expression of VDR protein CTD PMID:30698894 simvastatin increases expression ISO RGD:11484 6480464 Simvastatin results in increased expression of VDR mRNA CTD PMID:19262002 sodium arsenite increases expression ISO RGD:619561 6480464 sodium arsenite results in increased expression of VDR mRNA CTD PMID:22714537 , PMID:34032870 sodium atom multiple interactions ISO RGD:11484 6480464 VDR protein affects the reaction [FGF23 protein results in decreased transport of [Sodium co-treated with Phosphates]] CTD PMID:16076377 sotorasib multiple interactions ISO RGD:619561 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VDR mRNA CTD PMID:36139627 staurosporine increases cleavage ISO RGD:619561 6480464 Staurosporine results in increased cleavage of VDR protein CTD PMID:18832097 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of VDR mRNA, Streptozocin results in decreased expression of VDR protein CTD PMID:29953732 streptozocin multiple interactions EXP 6480464 Calcitriol inhibits the reaction [Streptozocin results in decreased expression of VDR mRNA], Calcitriol inhibits the reaction [Streptozocin results in decreased expression of VDR protein] CTD PMID:29953732 sunitinib increases expression ISO RGD:619561 6480464 Sunitinib results in increased expression of VDR mRNA CTD PMID:31533062 superoxide decreases abundance ISO RGD:11484 6480464 VDR protein results in decreased abundance of Superoxides CTD PMID:25201890 suramin multiple interactions ISO RGD:619561 6480464 Suramin inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:15930183 tamoxifen multiple interactions EXP 6480464 Tamoxifen inhibits the reaction [Estradiol results in increased expression of VDR protein] CTD PMID:1315250 tamoxifen multiple interactions ISO RGD:619561 6480464 Tamoxifen inhibits the reaction [Genistein results in increased expression of VDR mRNA], Tamoxifen inhibits the reaction [resveratrol results in increased expression of VDR mRNA] CTD PMID:12710998 terbufos affects response to substance ISO RGD:619561 6480464 VDR gene SNP affects the susceptibility to terbufos CTD PMID:23833127 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of VDR mRNA CTD PMID:31150632 titanium dioxide multiple interactions ISO RGD:11484 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VDR mRNA CTD PMID:29950665 tocopherol increases expression ISO RGD:619561 6480464 Tocopherols results in increased expression of VDR mRNA CTD PMID:12032296 trametinib multiple interactions ISO RGD:619561 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VDR mRNA CTD PMID:36139627 tributylstannane decreases expression ISO RGD:11484 6480464 tributyltin results in decreased expression of VDR mRNA CTD PMID:30027469 trichostatin A multiple interactions ISO RGD:619561 6480464 [decitabine co-treated with trichostatin A] results in increased expression of VDR mRNA more ... CTD PMID:14575637 more ... trimellitic anhydride increases expression ISO RGD:11484 6480464 trimellitic anhydride results in increased expression of VDR mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:11484 6480464 troglitazone results in decreased expression of VDR mRNA CTD PMID:19122273 troglitazone increases expression ISO RGD:11484 6480464 troglitazone results in increased expression of VDR mRNA CTD PMID:19122273 uranium atom decreases expression EXP 6480464 Uranium results in decreased expression of VDR mRNA CTD PMID:17118558 valproic acid multiple interactions ISO RGD:619561 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:21115105 more ... valproic acid decreases methylation ISO RGD:619561 6480464 Valproic Acid results in decreased methylation of VDR gene CTD PMID:29501571 valproic acid increases expression ISO RGD:619561 6480464 Valproic Acid results in increased expression of VDR mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:619561 6480464 Valproic Acid affects the expression of VDR mRNA CTD PMID:25979313 vincristine affects response to substance ISO RGD:619561 6480464 VDR gene polymorphism affects the susceptibility to Vincristine CTD PMID:15713801 vitamin D multiple interactions ISO RGD:619561 6480464 [bafilomycin A1 co-treated with Vitamin D] results in increased expression of VDR protein more ... CTD PMID:16280049 more ... vitamin D increases expression ISO RGD:619561 6480464 Vitamin D results in increased expression of VDR mRNA, Vitamin D results in increased expression of VDR protein CTD PMID:30698894 , PMID:33309619 vitamin D increases expression ISO RGD:11484 6480464 Vitamin D results in increased expression of VDR protein CTD PMID:30698894 vitamin D multiple interactions ISO RGD:11484 6480464 [Particulate Matter co-treated with Vitamin D] results in increased expression of VDR protein, [Silicon Dioxide co-treated with Vitamin D] results in increased expression of VDR protein CTD PMID:30698894 vitamin D increases activity ISO RGD:619561 6480464 Vitamin D analog results in increased activity of VDR protein CTD PMID:16280049 vitamin D increases expression EXP 6480464 Vitamin D deficiency results in increased expression of VDR protein CTD PMID:9525346 warfarin affects response to substance ISO RGD:619561 6480464 VDR gene SNP affects the susceptibility to Warfarin CTD PMID:28262345 , PMID:29298995 zidovudine multiple interactions ISO RGD:11484 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of VDR mRNA CTD PMID:11741158 zinc atom increases activity ISO RGD:619561 6480464 Zinc deficiency results in increased activity of VDR protein CTD PMID:18356318 zinc protoporphyrin affects abundance ISO RGD:619561 6480464 VDR gene polymorphism affects the abundance of zinc protoporphyrin CTD PMID:25963508 zinc(0) increases activity ISO RGD:619561 6480464 Zinc deficiency results in increased activity of VDR protein CTD PMID:18356318